Medley Pharmaceuticals
http://www.medley.com.br
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Medley Pharmaceuticals
Asia Spotlight: Emerging Markets At Stake As Viehbacher Departs Sanofi?
As emerging markets represent 32% of Sanofi
’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?
Emerging Markets At Stake As Viehbacher Departs Sanofi?
As emerging markets represent 32% of Sanofi’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?
India’s Intas Under Vietnamese Regulatory Lens?
Intas may be the latest to join dozens of Indian generic companies being investigated for supply of low quality generic drugs.
Novo Struggles In Japan, Sanofi Struggles With Distributors: Emerging Markets Earnings Roundup (Part 7)
Both Novo Nordisk and Sanofi had a bumpy start of the year in Asia and emerging markets. Novo saw insulin sales decline in Japan and Korea, while Sanofi grew only 6.5% in emerging markets, well below the company’s long-term guidance of double-digit growth.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice